4//SEC Filing
Savage William Jacob 4
Accession 0000950170-24-131211
CIK 0001816736other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 8:03 PM ET
Size
16.1 KB
Accession
0000950170-24-131211
Insider Transaction Report
Form 4
Savage William Jacob
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-25−5,263→ 5,258 totalExercise: $9.86Exp: 2031-09-13→ Common Stock (5,263 underlying) - Exercise/Conversion
Common Stock
2024-11-25$9.86/sh+5,263$51,893→ 45,668 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-25−8,920→ 30,004 totalExercise: $13.50Exp: 2032-12-28→ Common Stock (8,920 underlying) - Sale
Common Stock
2024-11-25$64.98/sh−8,737$567,696→ 45,851 total - Exercise/Conversion
Common Stock
2024-11-25$13.50/sh+8,920$120,420→ 54,588 total - Sale
Common Stock
2024-11-25$65.79/sh−3,542$233,018→ 42,309 total - Sale
Common Stock
2024-11-25$67.02/sh−1,904$127,613→ 40,405 total
Footnotes (6)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 18, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.44 to $65.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.44 to $66.41, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.44 to $67.32, inclusive.
- [F5]The shares underlying this option vest in 48 equal monthly installments following July 1, 2021, subject to the Reporting Person's continued service on each such vesting date.
- [F6]The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Disc Medicine, Inc.
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001951852
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 8:03 PM ET
- Size
- 16.1 KB